A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: The Women's Health Initiative Memory Study

Journal of the American Geriatrics Society

Volumn 56, Issue 8, 2008, Pages 1449-1458

  Johnson, Karen C ^a   Margolis, Karen L ^b   Espeland, Mark A ^c   Colenda, Christopher C ^d   Fillit, Howard ^e   Manson, JoAnn E ^f   Masaki, Kamal H ^g   Mouton, Charles P ^h   Prineas, Ronald ^c   Robinson, Jennifer G ⁱ   Wassertheil Smoller, Sylvia ^j  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

^e Alzheimers Drug Discovery Foundation   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF HAWAII   (United States)

^h UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁱ UNIVERSITY OF IOWA   (United States)

^j ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Blood pressure; Cognition; Dementia; Hypertension; Women's health

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; COGNITION; COMORBIDITY; DEMENTIA; DEMOGRAPHY; ETHNICITY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; PHYSICAL ACTIVITY; POSTMENOPAUSE; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; WOMEN'S HEALTH;

AGED; ALZHEIMER DISEASE; BLOOD PRESSURE; CALCIUM; COGNITION DISORDERS; CORONARY DISEASE; DRUG COMBINATIONS; ESTROGENS, CONJUGATED (USP); FEMALE; FOOD HABITS; HUMANS; HYPERTENSION; MEDROXYPROGESTERONE 17-ACETATE; MENTAL STATUS SCHEDULE; MIDDLE AGED; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PSYCHOMETRICS; RISK ASSESSMENT; RISK FACTORS; STATISTICS AS TOPIC; VITAMIN D;

EID: 51249104031     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.01806.x     Document Type: Article

References (56)

1. Hyman DP. VN characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001 345 : 479 486.
2. National Center for Health Statistics, Center for Disease Control and Prevention. Hypertension prevalence among adults, according to age, race, sex, and hispanic origin. In Health United States [on-line], 2002. Available at Accessed October 20, 2005.
3. Evans DA, Funkenstein HH, Albert MS et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989 262 : 2551 2556.
4. Rocca WA, Bonaiuto S, Lippi A et al. Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: A door-to-door survey in Appignano, Macerata Province, Italy. Neurology 1990 40 : 626 631.
5. Folstein MF, Bassett SS, Anthony JC et al. Dementia: Case ascertainment in a community survey. J Gerontol 1991 46 : M132 M138.
6. Canadian study of health and aging: Study methods and prevalence of dementia. Can Med Assoc J 1994 150 : 899 913.
7. Ernst RL, Hay JW. The US economic and social costs of Alzheimer's disease revisited. Am J Public Health 1994 84 : 1261 1264.
8. Barker A, Jones R, Jennison C. A prevalence study of age-associated memory impairment. Br J Psychiatry 1995 167 : 642 648.
9. Coria F, Gomez de Caso JA, Minguez L et al. Prevalence of age-associated memory impairment and dementia in a rural community. J Neurol Neurosurg Psychiatry 1993 56 : 973 976.
10. Larrabee GJ, Crook TH III. Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr 1994 6 : 95 104.
11. Feher EP, Larrabee GJ, Sudilovsky A et al. Memory self-report in Alzheimer's disease and in age-associated memory impairment. J Geriatr Psychiatry Neurol 1994 7 : 58 65.
12. Breteler MM. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective. Neurobiol Aging 2000 21 : 153 160.
13. Birkenhager WH, Forette F, Seux ML et al. Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med 2001 161 : 152 156.
14. Kivipelto M, Laakso MP, Tuomilehto J et al. Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: Potential for pharmacological intervention. CNS Drugs 2002 16 : 435 444.
15. Skoog I, Lernfelt B, Landahl S et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996 347 : 1141 1145.
16. Launer LJ, Ross GW, Petrovitch H et al. Midlife blood pressure and dementia: The Honolulu-Asia Aging study. Neurobiol aging 2000 21 : 49 55.
17. Kivipelto M, Helkala E-L, Laakso MP et al. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. BMJ 2001 322 : 1447 1451.
18. Guo Z, Fratiglioni L, Zhu L et al. Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use. Arch Neurol 1999 56 : 991 996.
19. in't Veld BA, Ruitenberg A, Hofman A et al. Antihypertensive drugs and incidence of dementia: The Rotterdam Study. Neurobiol Aging 2001 22 : 407 412.
20. Hajjar I, Catoe H, Sixta S et al. Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. J Gerontol A Biol Sci Med Sci 2005 60A : 67 73.
21. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991 265 : 3255 3264.
22. Prince MJ, Bird AS, Blizard RA et al. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ 1996 312 : 801 805.
23. Applegate WB, Pressel S, Wittes J et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the Systolic Hypertension in the Elderly Program. Arch Intern Med 1994 154 : 2154 2160.
24. Tzourio C, Anderson C, Chapman N et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003 163 : 1069 1075.
25. Forette F, Seux M-L, Staessen JA et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998 352 : 1347 1351.
26. Women's Health Initiative Investigators. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative study group. Control Clin Trials 1998 19 : 61 109.
27. Anderson G, Manson J, Wallace R et al. Implementation of the Women's Health Initiative study design. Ann Epidemiol 2003 13 : S5 S17.
28. Hays J, Hunt J, Hubbell F et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol 2003 13 : S18 S77.
29. Shumaker SA, Reboussin BA, Espeland MA et al. The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Controlled Clin Trials 1998 19 : 604 621.
30. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002 288 : 321 333.
31. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogens in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 2004 291 : 1701 1712.
32. Stefanick M, Cochrane B, Hsia J et al. The women's health initiative postmenopausal hormone trials: Overview and baseline characteristics of participants. Ann Epidemiol 2003 13 : S78 S86.
33. Shumaker SA, Legault C, Rapp SR et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study, a randomized controlled trial. JAMA 2003 289 : 2651 2662.
34. Rapp SR, Espeland MA, Shumaker SA et al. The effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study, a randomized controlled trial. JAMA 2003 289 : 26663 22672.
35. Shumaker SA, Legault C, Kuller L et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004 291 : 2947 2958.
36. Espeland MA, Rapp SR, Shumaker SA et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004 291 : 2959 2968.
37. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987 48 : 314 318.
38. McDowell I, Kristjansson B, Hill GB et al. Community screening for dementia: The Mini Mental State Exam (MMSE) and modified Mini-Mental State exam (3MS) compared. J Clin Epidemiol 1997 50 : 377 383.
39. Bravo G, Hebert R. Reliability of the modified Mini-Mental State examination in the context of a two-phase community prevalence study. Neuroepidemiology 1997 16 : 141 148.
40. Wassertheil-Smoller S, Anderson G, Psaty BM et al. Hypertension and its treatment in postmenopausal women: Baseline data from the Women's Health Initiative. Hypertension 2000 36 : 780 789.
41. Thiebaut ACM, Benichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: A simulation study. Stat Med 2004 23 : 3803 3820.
42. Farmer ME, White LR, Abbott RD et al. Blood pressure and cognitive performance. The Framingham Study. Am J Epidemiol 1987 126 : 1103 1114.
43. Morris MC, Scherr PA, Hebert LE et al. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 2001 58 : 1640 1646.
44. Wallace RB, Lemke JH, Morris MC et al. Relationship of free-recall memory to hypertension in the elderly. The Iowa 65+Rural Health Study. J Chronic Dis 1985 38 : 475 481.
45. Elias MF, D'Agostino RB, Elias PK et al. Neuropsychological test performance, cognitive functioning, blood pressure, and age: The Framingham Heart Study. Exp Aging Res 1995 21 : 369 391.
46. Cacciatore F, Abete P, Ferrara N et al. The role of blood pressure in cognitive impairment in an elderly population. Osservatorio Geriatrico Campano Group. J Hypertens 1997 15 : 135 142.
47. Cervilla JA, Prince M, Joels S et al. Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br J Psychiatry 2000 177 : 66 71.
48. Andre-Petersson L, Hagberg B, Janzon L et al. A comparison of cognitive ability in normotensive and hypertensive 68-year-old men: Results from population study "Men Born in 1914," in Malmo, Sweden. Exp Aging Res 2001 27 : 319 340.
49. Harrington F, Saxby BK, McKeith IG et al. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000 36 : 1079 1082.
50. Khachaturian AS, Zandi PP, Lyketsos CG et al. Antihypertensive medication use and incident Alzheimer disease: The Cache County Study. Arch Neurol 2006 63 : 686 692.
51. Elias MF, Wolf PA, D'Agostino RB et al. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study. Am J Epidemiol 1993 138 : 353 364.
52. Kivipelto M, Helkala EL, Hanninen T et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 2001 56 : 1683 1689.
53. Launer LJ, Masaki K, Petrovitch H et al. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995 274 : 1846 1851.
54. Hebert LE, Scherr PA, Bennett DA et al. Blood pressure and late-life cognitive function change: A biracial longitudinal population study. Neurology 2004 62 : 2021 2024.
55. Knopman D, Boland LL, Mosley T et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001 56 : 42 48.
56. Vermeer SE, Prins ND, den Heijer T et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003 348 : 1215 1222.